Stocksigma LogoStocksigma Logo

Bliss GVS Pharma Subsidiary Secures UK MHRA Approval for Mesalazine Suppositories

Bliss GVS Pharma Limited announced on 4th Nov'26 that its wholly owned UK subsidiary, Asterisk Lifesciences Ltd, has secured marketing authorization from

Bliss GVS Pharma Subsidiary Secures UK MHRA Approval for Mesalazine Suppositories

Bliss GVS Pharma Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 10:39 pm

Bliss GVS Pharma Subsidiary Secures UK MHRA Approval for Mesalazine Suppositories Bliss GVS Pharma Limited announced on 4th Nov'26 that its wholly owned UK subsidiary, Asterisk Lifesciences Ltd, has secured marketing authorization from the Medicines & Healthcare products Regulatory Agency (MHRA), UK. The regulatory approval covers Mesalazine 1g Suppositories, strengthening the company's product portfolio and market reach in the UK pharmaceutical segment.

Original exchange filing (PDF)

More announcements from Bliss GVS Pharma Ltd

All Bliss GVS Pharma Ltd announcements